Tyrosine kinase inhibitors
(Die Seite wurde neu angelegt: „ok some other kinases included... '''PAK-1 target''' {{tp|p=32313880|t=ä. PAK1-blockers: Potential Therapeutics against COVID-19? |pdf=|usr=}} {{tp|p=3234887…“)
Zum nächsten Versionsunterschied →
Version vom 8. Juli 2020, 08:06 Uhr
ok some other kinases included...
PAK-1 target
32313880 ä. PAK1-blockers: Potential Therapeutics against COVID-19?
32348877 ä. Chemical evolution for taming the ?pathogenic kinase? PAK1
Imatinib
32376403 ä. Imatinib might constitute a treatment option for lung involvement in COVID-19
BTK Bruton Tyrosine Kinase ibrutiib
32302379 2020. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
32503877 2020. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.
32433778 2020. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
akt PKB
32519895 2020. Is targeting Akt a viable option to treat advanced-stage COVID-19 patients?
Abelson tyrosine kinase
32399097 2020. Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.
p38 mapk
32422320 2020. p38 MAPK inhibition: A promising therapeutic approach for COVID-19.
